Skip to content

Clarithromycin Impurity 2

Clarithromycin Impurity 2

Product Description
CAT No.
ALN-C040022
CAS No.
1054651-74-9
Mol. F.
C37H67NO13
Mol. Wt.
733.9
Stock
Please Inquire
Chemical Name : (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-(((2R,4R,5S,6S)-4,5-Dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
Smiles : CO[C@@]([C@@H]([C@H]([C@@H]([C@H](C(O[C@@H]1CC)=O)C)O[C@H](O[C@H]2C)C[C@@](O)([C@H]2O)C)C)O[C@H](O[C@@H]3C)[C@@H]([C@H](C3)N(C)C)O)(C[C@H](C([C@@H]([C@H]([C@](O)1C)O)C)=O)C)C
Inchi : InChI=1S/C13H13BrClN5O3S/c1-2-7-20(19-21)24(22,23)18-13-11(12(15)16-8-17-13)9-3-5-10(14)6-4-9/h3-6,8H,2,7H2,1H3,(H,16,17,18)

Stability indicating HPLC-ECD method for the analysis of clarithromycin in pharmaceutical dosage forms: method scaling versus re-validation

By Makoni, Pedzisai A.; Chikukwa, Mellisa T. R.; Khamanga, Sandile M. M.; Walker, Roderick B.nFrom Scientia Pharmaceutica (2019), 87(4), 31

Stability indicating Rp-Hplc method development and validation for the simultaneous estimation of gemcitabine and clarithromycin in bulk and pharmaceutical dosage form

By Kumar, Y. Anil; Sirisha, Y.; Harini, A. L.; Prathyusha, A. – From World Journal of Pharmaceutical Research (2018), 7(8Spec.Iss.), 1-8

Request For Quotation